(Q39152916)

9 September 2017

1 reference

title

Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date (English)

1 reference

9 September 2017

Sandström EG

1

1 reference

9 September 2017

Kaplan JC

series ordinal

2

1 reference

9 September 2017

language of work or name

1 reference

1 September 1987

1 reference

9 September 2017

1 reference

9 September 2017

volume

34

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

372-390

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198734030-00004

9 September 2017

exact match

0 references

cites work

Grim projections for AIDS epidemic

1 reference

12 December 2020

In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

1 reference

12 December 2020

Induction of Endogenous Virus and of Thymidine Kinase by Bromodeoxyuridine in Cell Cultures Transformed by Friend Virus

1 reference

12 December 2020

Rifabutine inhibits HTLV-III.

1 reference

12 December 2020

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase

1 reference

12 December 2020

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

1 reference

12 December 2020

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

1 reference

12 December 2020

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

1 reference

12 December 2020

Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men.

1 reference

12 December 2020

Lymphocytotoxic antibodies in the acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome.

1 reference

12 December 2020

AIDS therapy by blocking CD4 + cells

1 reference

12 December 2020

Human immunodeficiency viruses

1 reference

12 December 2020

Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex

1 reference

12 December 2020

Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide

1 reference

12 December 2020

Immunosuppression following alloantigen exposure: a role for lymphocyte Fc gamma-receptor blocking antibodies.

1 reference

12 December 2020

AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa

1 reference

12 December 2020

Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells.

1 reference

12 December 2020

Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro.

1 reference

12 December 2020

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

1 reference

12 December 2020

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

1 reference

12 December 2020

Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

12 December 2020

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

1 reference

12 December 2020

Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon

1 reference

12 December 2020

Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin

1 reference

12 December 2020

Interleukin regulation of the immune system (IRIS) in male homosexuals with acquired immune deficiency disease syndrome

1 reference

12 December 2020

The use of plasmapheresis, lymphocytapheresis, and staph protein-A immunoadsorption as an immunomodulatory therapy in patients with AIDS and AIDS-related conditions

1 reference

12 December 2020

Specific targets for antiviral drugs.

1 reference

12 December 2020

The Walter Reed staging classification for HTLV-III/LAV infection.

1 reference

12 December 2020

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

1 reference

12 December 2020

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

12 December 2020

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

12 December 2020

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

1 reference

12 December 2020

In vitro effect of foscarnet on expansion of T-cells from people with LAS and AIDS

1 reference

12 December 2020

Nonoxynol-9 and HTLV-III.

1 reference

12 December 2020

Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo

1 reference

12 December 2020

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

12 December 2020

Expression of interleukin 2 receptors on activated human B cells

1 reference

12 December 2020

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes

1 reference

12 December 2020

Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus

1 reference

12 December 2020

Inhibition of HTLV-III/LAV replication by foscarnet

1 reference

12 December 2020

Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat

1 reference

12 December 2020

Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome

1 reference

12 December 2020

Gamma-interferon is one of several direct B cell-maturing lymphokines

1 reference

12 December 2020

Ribavirin and inosiplex: a review of their present status in viral diseases

1 reference

12 December 2020

Mechanism of action of thymosin. II. Effects of aspirin and thymosin on enhancement of IL-2 production

1 reference

12 December 2020

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

1 reference

12 December 2020

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

1 reference

12 December 2020

Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

1 reference

12 December 2020

The structure of the heteropolytungstate (NH4)17NA|NaW21Sb9O86|.cntdot.14H2O. An inorganic cryptate

1 reference

12 December 2020

Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus

1 reference

12 December 2020

Interleukin 2: a review

1 reference

12 December 2020

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

12 December 2020

Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir

1 reference

12 December 2020

Phosphonoformate inhibition of visna virus replication

1 reference

12 December 2020

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

1 reference

12 December 2020

Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon

1 reference

12 December 2020

HTLV-III in symptom-free seronegative persons

1 reference

12 December 2020

Selective inhibition of replication of the AIDS-associated virus HTLV-III/LAV by synthetic D-penicillamine.

1 reference

12 December 2020

In situ hybridization--application to gene localization and RNA detection

1 reference

12 December 2020

Effects of systemic in vivo interleukin-2 (IL-2) reconstitution in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) on phenotypes and functions of peripheral blood mononuclear cells (PBMC)

1 reference

12 December 2020

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 reference

12 December 2020

Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results

1 reference

12 December 2020

Increase in intracisternal A-type particles in Friend cells during inhibition of Friend virus (SFFV) release by interferon or azidothymidine

1 reference

12 December 2020

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

1 reference

12 December 2020

In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate.

1 reference

12 December 2020

Phosphonoformate Inhibits Reverse Transcriptase

1 reference

12 December 2020

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions

1 reference

12 December 2020

Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV

1 reference

12 December 2020

Synthesis and biological activity of several amino analogues of thymidine

1 reference

12 December 2020

Prospects of therapy for infections with human T-lymphotropic virus type III.

1 reference

12 December 2020

Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.

1 reference

12 December 2020

Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms

1 reference

12 December 2020

A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathy

1 reference

12 December 2020

The mechanism of retrovirus suppression of human T cell proliferation in vitro

1 reference

12 December 2020

Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.

1 reference

12 December 2020

Implantation of cultured thymic fragments in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Prospects for the prevention and therapy of infections with the human immunodeficiency virus

1 reference

12 December 2020

Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Thymosin in the staging and treatment of HTLV-III positive homosexuals and hemophiliacs with AIDS-related immune dysfunction.

1 reference

12 December 2020

Task force formed to coordinate study, testing of AIDS therapies

1 reference

12 December 2020

A second post-transcriptional trans-activator gene required for HTLV-III replication

1 reference

12 December 2020

Longitudinal assessment of persistent generalized lymphadenopathy (PGL) in homosexual men.

1 reference

12 December 2020

Ribavirin enters cerebrospinal fluid.

1 reference

12 December 2020

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

12 December 2020

Suramin treatment for AIDS

1 reference

12 December 2020

Trisodium Phosphonoformate, a New Antiviral Compound

1 reference

12 December 2020

The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70

1 reference

12 December 2020

Short-term results with suramin for AIDS-related conditions

1 reference

12 December 2020

Thymic dysplasia in acquired immunodeficiency syndrome

1 reference

12 December 2020

Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.

1 reference

12 December 2020

Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

1 reference

12 December 2020

Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia

1 reference

12 December 2020

Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

1 reference

12 December 2020

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

12 December 2020

Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro.

1 reference

12 December 2020

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

12 December 2020

Infection of monocyte/macrophages by human T lymphotropic virus type III.

1 reference

12 December 2020

Thymus involution in the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro.

1 reference

12 December 2020

Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzene

1 reference

12 December 2020

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

12 December 2020

Naturally occurring persistent feline oncornavirus infections in the absence of disease

1 reference

12 December 2020

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

1 reference

12 December 2020

10.2165/00003495-198734030-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

9 September 2017

1026162929

0 references

1 reference